Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2005, p. 2991-2993, Vol. 43, No. 6
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.6.2991-2993.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute of Virology, University of Milan, Milan,1 Transfusion Medicine and Hematology Department, Hospital of Sondrio, Sondrio, Italy,2 Scientific Affairs, Roche Molecular Systems, Rotkreuz, Switzerland3
Received 16 August 2004/ Returned for modification 14 November 2004/ Accepted 1 February 2005
We evaluated the COBAS Ampliscreen hepatitis B virus (HBV) test using standards, seroconversion panels, consecutive donations, and samples from patients with abnormal alanine aminotransferase and chronic hepatitis C. Specificity was 100% and sensitivity was 20 IU/ml. In seroconversion panels, HBV DNA was detected up to 4 to 18 days before HBsAg, suggesting that this assay is useful in shortening the infectious window phase.
Contributing members of the Italian Group for the Study of Transfusion Transmissible Diseases are listed in Acknowledgments.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»